Keywords: در مدل سازی سیلیکا; biotechnology; in silico modeling; molecular modeling; monoclonal antibody; oxidation;
مقالات ISI در مدل سازی سیلیکا (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: در مدل سازی سیلیکا; amorphous; solid dispersion; QSPR; structure property relationship; in silico modeling; calorimetry (DSC); microscopy; X-ray powder diffractometry; preformulation; API; active pharmaceutical ingredient; ASD; amorphous solid dispersion; DSC; differential s
Keywords: در مدل سازی سیلیکا; solubility; in silico modeling; micelle; oral absorption; phospholipids;
Keywords: در مدل سازی سیلیکا; oral drug delivery; in silico modeling; cytochrome P450; drug interactions; food interactions; gastrointestinal transit; transporters;
Keywords: در مدل سازی سیلیکا; in silico modeling; dissolution; mathematical model; precipitation; in vivo models;
Keywords: در مدل سازی سیلیکا; absorption; gastrointestinal transit; permeability; solubility; computational absorption, distribution, metabolism, and excretion; cyclodextrins; in vitro models; in silico modeling; absorption enhancer;
Keywords: در مدل سازی سیلیکا; physiology-based pharmacokinetics; pharmacokinetics; drug resistance; onychomycosis; in silico modeling;
Keywords: در مدل سازی سیلیکا; Fish waste; Cyclic dichroism (CD); FTIR; In silico modeling; Molecular docking;
Keywords: در مدل سازی سیلیکا; biopharmaceuticals characterization; biophysical models; in silico modeling; light scattering (static); monoclonal antibody; protein formulation;
Keywords: در مدل سازی سیلیکا; amorphous; solid dispersion; solid solutions; thermodynamics; kinetics; in silico modeling; molecular dynamics; molecular modeling; QSPR; physical stability; API; active pharmaceutical ingredient; ASD; amorphous solid dispersion; DFT; density functional t
Keywords: در مدل سازی سیلیکا; ab initio calculations; crystal polymorphism; in silico modeling; infrared spectroscopy; moleular modeling;
Keywords: در مدل سازی سیلیکا; ALR2; aldose reductase; ALR1; aldehyde reductase; ARIs; aldose reductase inhibitors; AKR1B1; aldo-keto reductase family1 member1; AKR1B10; aldo-keto reductase family1 member10; Glc; glucose; Ep; epalrestat; Aldose reductase inhibition; Diabetic compli
Keywords: در مدل سازی سیلیکا; molecular dynamics; force field; in silico modeling; dehydration; crystallography; hydrate;
Keywords: در مدل سازی سیلیکا; artificial neural networks; in silico modeling; dry powder inhaler; next-generation impactor; in vitro performance; fine particle fraction;
Keywords: در مدل سازی سیلیکا; in silico modeling; disposition; formulation; gastrointestinal; mathematical model; oral drug delivery; oral absorption; physiologically based pharmacokinetic modeling;
Keywords: در مدل سازی سیلیکا; pulmonary drug delivery; in silico modeling; drug delivery systems; Monte Carlo; drug transport; particle size;
Keywords: در مدل سازی سیلیکا; HIV/AIDS; pharmacokinetics; computational biology; Monte Carlo; drug design; mathematical model; mucosal delivery; dynamic simulation; in silico modeling; biophysical models;
Keywords: در مدل سازی سیلیکا; in silico modeling; QSAR; transporters; computational ADME; high-throughput technologies; AUC; area under the curve; BCRP; breast cancer resistance protein; DDI; drug-drug interaction; fup; protein unbound fraction in plasma; ITC; International Transpor
Keywords: در مدل سازی سیلیکا; SPRBYCGPZWLDEV-UHFFFAOYSA-N; WKAMINDQUAMGKO-UHFFFAOYSA-N; Arabidopsis thaliana; Brassicaceae; In silico modeling; Kohonen; Self-organizing maps; In vivo screening; Plant growth regulators; Pesticides; Agrochemicals;
Keywords: در مدل سازی سیلیکا; solid dispersion; Biopharmaceutics Classification System; crystallization; dissolution; drug-excipient interaction; formulation; in silico modeling; oral drug delivery; polymeric drug delivery systems; supersaturation;
Keywords: در مدل سازی سیلیکا; Solubility; High throughput technologies; Analytical chemistry; Computational ADME; In silico modeling; Computer aided drug design; ROC curve analysis;
Keywords: در مدل سازی سیلیکا; Microwave; Chitosan; PEGylation; Thiolation; Mucoadhesion; In silico modeling;
Keywords: در مدل سازی سیلیکا; protein formulation; oxidation; biophysical models; protein structure; stabilization; computer aided drug design; in silico modeling; molecular dynamics; molecular modeling; physicochemical properties;
Keywords: در مدل سازی سیلیکا; ADME; blood-brain barrier; computational ADME; drug transport; unbound brain-to-plasma concentration ratio; machine learning; in silico modeling;
Keywords: در مدل سازی سیلیکا; pharmacokinetic/pharmacodynamic models; simulation; drug interaction; cancer chemotherapy; in silico modeling;
Keywords: در مدل سازی سیلیکا; factorial design; coating; in silico modeling; mathematical model; simulations; tablet;
Keywords: در مدل سازی سیلیکا; oxytetracycline; physiologically based pharmacokinetic (PBPK) modeling; dogs; tetracycline antibiotics; Food Animal Residue Avoidance Databank (FARAD); computational ADME; mathematical model; pharmacokinetics; in silico modeling; disposition;
Keywords: در مدل سازی سیلیکا; N-oxide; oxidation; ab initio calculations; drug molecules; forced conditions; chemical stability; degradation products; chromatography; in silico modeling;
Keywords: در مدل سازی سیلیکا; intestinal absorption; salt selection; bioequivalence; biopharmaceutics classification system (BCS); in silico modeling; dissolution; food effects; formulation; gastrointestinal transit; oral absorption
Keywords: در مدل سازی سیلیکا; analytical biochemistry; bioinformatics; biotechnology; deamidation; degradation products; immune response; in silico modeling; monoclonal antibody; oxidation; pharmacokinetics;
Keywords: در مدل سازی سیلیکا; dissolution; diffusion; dissolution rate; mathematical model; in silico modeling; simulations; particle size; in vitro models; solubility; computer-aided drug design
Keywords: در مدل سازی سیلیکا; quality by design (QBD); process analytical technology (PAT); mathematical model; materials science; in silico modeling;
Keywords: در مدل سازی سیلیکا; isoconversion; accelerated stability; shelfâlife; Arrhenius fitting; kinetics; stability; chemical stability; mathematical model; in silico modeling;
Keywords: در مدل سازی سیلیکا; in silico modeling; molecular dynamics; log P; partition coefficient; drug interactions; linear interaction energy; extractables/leachables; molecular modeling; polymers;
Keywords: در مدل سازی سیلیکا; tissue partition; physicochemical properties; population pharmacokinetic/pharmacodynaMic Models; drug transport; active transport; QSPR; Monte Carlo; in silico Modeling; computational ADME; computational biology;
Keywords: در مدل سازی سیلیکا; clinoptilolite; cationic surfactant; adsorption; excipient; diclofenac sodium; neural networks; in silico modeling; dissolution; antiedematous activity; dose-response;
Keywords: در مدل سازی سیلیکا; Quality by Design (QbD); bioavailability; biopharmaceutics classification system (BCS); clinical trial simulations; controlled delivery; in silico modeling; in vitro models; in vitro/in vivo correlations (IVIVC); oral drug delivery; pharmacokinetics; phar
Keywords: در مدل سازی سیلیکا; Renin inhibitor; MM-GB/SA; 3D-QSAR; In silico modeling; MD simulation;
Keywords: در مدل سازی سیلیکا; Permeability; In silico modeling; Absorption potential; Drug transport; Mucosal delivery; Mucosal drug delivery; Trans-mucosal drug delivery;
Biopharmaceutical Characterization and Oral Efficacy of a New Rapid Acting Antidepressant Ro 25-6981
Keywords: در مدل سازی سیلیکا; oral absorption; caco-2 cells; gastrointestinal; permeability; CYP enzymes; microsomes; in vitro models; in silico modeling; metabolism; physicochemical;
Mechanistic Physiologically Based Pharmacokinetic (PBPK) Model of the Heart Accounting for Inter-Individual Variability: Development and Performance Verification
Keywords: در مدل سازی سیلیکا; in silico modeling; disposition; pharmacokinetic/pharmacodynamic models; pharmacokinetics; physiological model;
In vitro and in silico study of the biological activity of manganese(III) inverse-[9-MC-3]-metallacrowns and manganese(II) complexes with the anti-inflammatory drugs diclofenac or indomethacin
Keywords: در مدل سازی سیلیکا; Manganese compounds; Cytotoxicity; DNA-binding; Albumin-binding; In silico modeling;
How Sensitive Are Transdermal Transport Predictions by Microscopic Stratum Corneum Models to Geometric and Transport Parameter Input?
Keywords: در مدل سازی سیلیکا; in silico modeling; transdermal; transdermal drug delivery; passive diffusion/transport; percutaneous; permeability; skin;
Quinoxaline derivatives as new inhibitors of coxsackievirus B5
Keywords: در مدل سازی سیلیکا; Antiviral activity; Enteroviruses; Viral protein VP1; in silico modeling;
Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: In vitro-in silico approach
Keywords: در مدل سازی سیلیکا; Solid dispersions; Poorly soluble drugs; Bioavailability; in silico modeling;
Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus
Keywords: در مدل سازی سیلیکا; In silico modeling; Stereo-electronic profiles; Molecular electrostatic potentials (MEPs); Renilla luciferase reporter replicon; Autophagy; Cathepsin B;
In Silico Prediction of hPXR Activators Using Structure-Based Pharmacophore Modeling
Keywords: در مدل سازی سیلیکا; PXR; cytochrome P450; computational ADME; induction; in silico modeling; molecular modeling;
Estimation of Interindividual Variability of Pharmacokinetics of CYP2C9 Substrates in Humans
Keywords: در مدل سازی سیلیکا; CYP enzymes; pharmacokinetics; Monte Carlo simulation; pharmacogenetics; in silico modeling;
Usefulness of PBPK Modeling in Incorporation of Clinical Conditions in Personalized Medicine
Keywords: در مدل سازی سیلیکا; in silico modeling; special population; genetic polymorphisms; disease state; pregnancy; pediatric; geriatric;
New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy
Keywords: در مدل سازی سیلیکا; DNA repair; ERCC1; XPA; In silico modeling; Drug discovery; Cancer